Hypermarcas profit advances and reaches R $ 124,7 million

Accordingly, the company recorded net revenues increased 22%, to $ 1.03 billion.
Hypermarcas recorded net income of r $ 124,7 million in the fourth quarter, a high of 151% in comparison with R $ 49,6 million obtained in the same period last year.
The company's net revenue advanced 22 percent, to $ 1.03 billion.
The main growth occurred in Farma-segment of the company that manufactures pharmaceutical products, with brands such as Benegrip, Asa and Epocler. This Division had net revenues of r $ 494,4 million in the quarter, a growth of 31% compared to same period in 2011.
"The company has redefined, in 2012, the process of innovation and renewal of its portfolio of drugs, aiming at better prioritization of projects with higher potential sales and profitability," the company explained in quarterly results.
In the consumer division, the expansion was 14.5% in the quarter, to $ 532,3 million.
The company's marketing costs increased by 28.2% in the period, with R $ 182,5 million.
At the end of last year, net debt was r $ Hypermarcas 2.7 billion, or $ 43.4 million below the observed at the end of 2011.
Ebitda (earnings before interest, taxes, depreciation and amortization) rose 71% to r $ 230,2 million.
Throughout the past year, Hypermarcas profited $ 203,9 million, compared to a loss of r $ 54.7 million in 2011. According to the company, net revenue totaled r $ 3.9 billion, with organic growth (excluding acquisitions) of 16.5%.